galantamine has been researched along with oxidopamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Shimohama, S | 1 |
Ashihara, E; Inden, M; Kitamura, Y; Shimohama, S; Takata, K; Tooyama, I; Yanagisawa, D | 1 |
El-Tahan, RA; Gowayed, MA; Kamel, MA; Mahmoud, SA; Michel, TN | 1 |
1 review(s) available for galantamine and oxidopamine
Article | Year |
---|---|
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord | 2009 |
2 other study(ies) available for galantamine and oxidopamine
Article | Year |
---|---|
α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine Agonists; Galantamine; Locomotion; Male; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Nicotinic; Substantia Nigra | 2016 |
Galantamine in rheumatoid arthritis: A cross talk of parasympathetic and sympathetic system regulates synovium-derived microRNAs and related pathogenic pathways.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cholinesterase Inhibitors; Galantamine; Gene Expression Regulation; Male; MicroRNAs; Nicotinic Antagonists; Oxidopamine; Parasympathetic Nervous System; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympatholytics; Synovial Membrane; Tyrosine 3-Monooxygenase | 2020 |